APO-OLMESARTAN/AMLODIPINE/HCTZ 40/10/25 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/25 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-olmesartan/amlodipine/hctz 40/10/25 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/25 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.9 mg; hydrochlorothiazide, quantity: 25 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: isopropyl alcohol; silicified microcrystalline cellulose; povidone; lactose monohydrate; pregelatinised maize starch; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - apo-olmesartan/amlodipine/hctz 40/10/25 mg is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

APO-Perindopril Arginine/Amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-Perindopril Arginine/Amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Auro-Amlodipine 5 mg Namibia - English - Namibia Medicines Regulatory Council

auro-amlodipine 5 mg

aurobindo pharma (pty) ltd - amlodipine besilate - tablet - each tablet contains amlodipine besilate equivalent to amlodipine 5,0 mg

Auro-Amlodipine 10 mg Namibia - English - Namibia Medicines Regulatory Council

auro-amlodipine 10 mg

aurobindo pharma (pty) ltd - amlodipine besilate - tablet - each tablet contains amlodipine besilate equivalent to amlodipine 10,0 mg

ALKEM AMLODIPINE amlodipine (as besilate) 10 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

alkem amlodipine amlodipine (as besilate) 10 mg tablet bottle

pharmacor pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet - excipient ingredients: magnesium stearate; silicon dioxide; calcium phosphate; microcrystalline cellulose; sodium starch glycollate type a - hypertension,alkem amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of alkem amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor.,angina,alkem amlodipine is indicated for the first line treatment of chronic stable angina. alkem amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.

ALKEM AMLODIPINE amlodipine (as besilate) 5 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

alkem amlodipine amlodipine (as besilate) 5 mg tablet bottle

pharmacor pty ltd - amlodipine besilate, quantity: 6.93 mg (equivalent: amlodipine, qty 5 mg) - tablet - excipient ingredients: calcium phosphate; magnesium stearate; microcrystalline cellulose; sodium starch glycollate type a; silicon dioxide - hypertension,alkem amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of alkem amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor.,angina,alkem amlodipine is indicated for the first line treatment of chronic stable angina. alkem amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.

TN-AMLODIPINE amlodipine besylate 5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

tn-amlodipine amlodipine besylate 5 mg tablet blister pack

gm pharma international pty ltd - amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate type a; magnesium stearate - 1. hypertension amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor.,2. angina amlodipine is indicated for the first line treatment of chronic stable angina. amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.

PIP-AMLODIPINE amlodipine besylate 5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pip-amlodipine amlodipine besylate 5 mg tablet blister pack

ipca pharma (australia) pty ltd - amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate type a; magnesium stearate - 1. hypertension amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor.,2. angina amlodipine is indicated for the first line treatment of chronic stable angina. amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.

IPCA-AMLODIPINE amlodipine besylate 5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

ipca-amlodipine amlodipine besylate 5 mg tablet blister pack

ipca pharma (australia) pty ltd - amlodipine besilate, quantity: 6.935 mg (equivalent: amlodipine, qty 5 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate type a; magnesium stearate - 1. hypertension amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor.,2. angina amlodipine is indicated for the first line treatment of chronic stable angina. amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.